Navigation Links
Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
Date:9/26/2007

eting the study, titled "Increasing the Capacity of the Nation's Small and Disadvantaged Businesses." They set out to measure the impact of the SDB program on minority business performance and examine how the personal net worth ceiling has affected SDB capacity. They also assessed the impact of the SDB program on national output and employment.

The study's results outline the barriers that small disadvantaged businesses face in pursing success in today's environment, including the ability to build capacity and satisfy corporate demand. The goals of the research findings are to close the gap and help minority businesses achieve the size, scale and capabilities necessary for global competition.

"With greater capacity, SDBs are able to operate more successfully in the public and private sectors," said Elsie L. Scott, Ph.D., CBCF's president and chief executive officer. "Their greater success expands overall economic output and generates jobs, income and wealth in the economy and especially in underserved communities."

The results reveal the following:

-- Small disadvantaged businesses still experienced an annual disparity in

revenue of $900,000 in comparison to non-minority owned small business

concerns with similar characteristics.

-- The $750,000 personal net worth ceiling of the SDB program has not been

adjusted for inflation in nine years. Therefore, the current real value

of the ceiling is $558,070.

-- The capacity of small disadvantaged businesses and the personal net

worth of their owners are closely related.

-- A personal net worth ceiling that is set too low causes other economic

hardships.

"GlaxoSmithKline and the Congressional Black Caucus Foundation partnered together to improve ways to help small disadvantaged businesses succeed among the competition," said Chris Viehbacher, president of U.S. Pharmaceuticals for GSK. "This study shows the success of tha
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. LCA Hails Congressional Front Against Pink Camel Cigarette Campaign
2. Bird flu may cause a blackout in New Zealand
3. AIDS toll set to exceed Black Death
4. Physical activity less among black girls
5. Black tea said to lower cholesterol
6. FDA gives “black box warning” against three asthma drus
7. Women and Black Patients have less chances to survive a Heart Attack
8. Poisoning by fruits similar to blackberries
9. Blacks decline Lung cancer surgery
10. Fewer Blacks Undergo Lung Cancer Surgery
11. Home Remedies More Used By Blacks And Native Americans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...e likely to miscarrry after IVF treatment- but los... say doctors. They are urging overweight women to ...mbarking on fertilty treatments. Obese women have ...s conceiving naturally, and studies have shown tha...
...contained mechanical heart has been implanted and ... hour operation, a US hospital has announced. The ... in the development of an artificial replacement h...ul, the device could help thousands of patients wh...
...lp of fertility treatment grow into emotionally an...w research. The world's first study that followed ...lescence showed that youngsters who had been conce...ts do not suffer any more psychological problems t...
... remains a therapeutic challenge for many practisi...ms of medicine has taken its stride. Acupuncture v...d with some practitioners. Dr. Dominik Irnich of L...as done a study on this basis and found that when ...
Other Medicine News:
(Date:9/3/2008)...umatology Research and Education Foundation,s Wit... in Detecting, Treating and Un...For the first time during its,unprecedented initia...American College of Rheumatology Research and Educ...ired from research funded by the Within Our,Reach:...
(Date:9/3/2008)...nal Vascular Disease Awareness Month, CHARLOTTESV...aceuticals,LLC, a clinical-stage drug-development ...t of unmet medical needs, announced today that it ...cal trial of its lead drug,candidate trans sodium ...81,on the clinicaltrials.gov Website, is investiga...
(Date:9/3/2008)...3 /- Panacea Pharmaceuticals,Inc. to...,413,737 covering,antibodies against human asparty...tary human cancer biomarker and therapeutic target... with the Massachusetts Institute of,Technology (M... this patent,for development of human cancer diagn...
(Date:9/3/2008)...iscuss Phase 3 Plans with FDA, PRINCETON, N.J., S...nnounced today that it successfully completed two ...any,s new, innovative low-dose, once-weekly,contr... internal product,code AG-200-15. The Phase 2b saf...y endpoint of ovulation suppression, cycle control...
Breaking Medicine Technology:New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4CBaySystems Commitment to Continued Improvement Leads to High Industry Recognition 10251 1CBaySystems Commitment to Continued Improvement Leads to High Industry Recognition 10251 2Intervention program boosts health reduces symptoms in breast cancer patients 10247 1Intervention program boosts health reduces symptoms in breast cancer patients 10247 2Intervention program boosts health reduces symptoms in breast cancer patients 10247 3Mental health screenings risk behavior interventions needed in juvenile justice system 10246 1Mental health screenings risk behavior interventions needed in juvenile justice system 10246 211 Minutes or 90 Seconds 3F 10241 111 Minutes or 90 Seconds 3F 10241 2
...ofrontera AG (DSE: B8F) announces today,that it ha...ng part,of its phase IIb/III clinical trial starte...the active substance 5-aminolevulinic acid,(ALA) w...ificantly,superior to placebo in the treatment of ...mic therapy, which eliminates tumor tissue,through...
...at Study in American Heart Journal , ,WINNIPEG, M...Amex:MCU), a cardiovascular focused, biopharmaceut...ollow-up results from the,STRATEGY (Single High-Do...sus Abciximab and Bare Metal Stent In Acute Myocar...edition of the Journal,of the American College of ...
Other Medicine Technology:Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5
...ro Electronic Pipette is ideal for all liquid hand...ollow display, ergonomically-placed operating butt...etting, dispensing, reverse pipetting and diluting...the simple functions of a manual pipette without a...
...ign for Unparalleled Comfort Pick one of our pipe...e trigger and ejector positionsright where they sh...r pipettors are ergonomically designed to help avo... of pipetting. Productivity In The Palm Of Your H...
...ign for Unparalleled Comfort Pick one of our pipe...e trigger and ejector positionsright where they sh...r pipettors are ergonomically designed to help avo... of pipetting. Productivity In The Palm Of Your H...
...nomic solution and best value in high performance ... and ultra lightweight design reduce hand fatigue ...ever tip ejector , Color coding for easy volume id...er performance use Hamilton AdvanTip Low Retention...
Medicine Products: